Both in R&D — Physical & Biological Sciences
Incyte Genomics vs MaxCyte
Over the past year INCY returned +11.6% and MXCT returned −21.6%; their daily moves had a correlation of 0.07.
INCY +11.6% MXCT −21.6%Growth of $1, one year, split-adjusted
| Metric | INCY | MXCT |
|---|---|---|
| Price | $118.01 | $1.31 |
| Market cap | $24.05B | $135.2M |
| Today | −3.94% | −5.76% |
| 1 month | +4.0% | +26.0% |
| 6 months | +20.7% | +50.3% |
| Year to date | +19.5% | −15.5% |
| 1 year | +14.7% | −18.6% |
| Revenue growth (YoY) | +14.0% | −14.5% |
| Gross margin | 93.0% | 77.0% |
| Net margin | −50.4% | −122.0% |
| P/E (TTM) | 59.6× | — |
| Price / sales | 4.0× | 4.4× |
| Net cash | $3.82B | $105.7M |
| Dividend yield | — | — |
| Volatility (60d) | 29.8% | 83.1% |
| Short % of float | 5.9% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).